Until law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be used to treat chronic kidney problems. There is yet another research, published in JAMA Psychiatry on February 25, titled Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial that explores if GLP-1 receptor agonist semaglutide reduce alcohol consumption and cravings in adults with alcohol use disorder.

What Do Studies Say?

The research was conducted over a period of 9 weeks, where in the randomized clinical trial, the participants who were administered semaglutide, it led to reductions in some but not all measures of weekly consumptions. It also reduced weekly alcohol and craving related to placebo, and also led to a greater relative reduction in cigarettes per day.

The research also found that weekly injections of semaglutide, which is the active ingredient in weight loss drugs like Wegovy also helped reduce cravings in people with alcohol use disorder.

The lead author Christian Hendershot said that these findings will help in developing new approaches to treat alcoholism. "Two drugs currently approved to reduce alcohol consumption aren't widely used. The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder," said Hendershot in news release by the University of Southern California's Institute for Addiction Research, where he is the director.

The study is government-funded research and was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.

How Was The Study Conducted?

The study was small, and took in account for only 48 adults over two months, thus experts say that it is not yet clear how safe these drugs are for people who do not need to lose weight. Though the results do add up with the evidence form animal studies on drugs like Ozempic and Wegovy on how it helps manage cravings, not just for food, but also for tobacco and alcohol. Scientists are also studying these drugs on smokers, people with opioid addiction and cocaine users.

Co-author Dr Klara Klein of the University of North Carolina at Chapel Hill who treats people with obesity and diabetes said, "This is such promising data. And we need more of it. We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."

Why Does It Work So Well Against Alcoholism?

The GLP-1 receptor agonists work by mimicking hormones GLP-1 in the gut and brain that regulates appetite and feelings of fullness. This response is what helps one lose weight, and what helps one curb their craving for alcohol. These drugs that mimic the functioning of your brain, which is responsible to tell your body when to stop consuming, are the same hormones that tell your body about other kinds of consumptions, including alcohol. Therefore by consuming the weight loss drugs one can treat alcohol use disorder.

However, the researchers have pointed out on the limited data on the research and have suggested to continue using the three approved drugs by the National Institute on Alcohol Abuse and Alcoholism and Substance Abuse and Mental Health Services Administration, namely, Disulfiram, Naltrexone, and Acamprosate to treat alcohol use disorder until large studies confirm these findings.

The Democratic Republic of the Congo is actively expanding Ebola treatment capacity as the country battles its worst and fastest-growing Ebola outbreak. But a growing shortage of health workers is threatening the ability to run the new treatment centres and contain and manage transmission and infections.

According to the latest figures by Congolese authorities on September 23, the outbreak has across into seven provinces, with 7,773 confirmed cases and 3,759 deaths. The WHO says transmission remains out of control, even though cases are going down in some areas.

The situation is particularly grim in North Kivu, where cases increased by 73% over three weeks. At the same time, cases fell by 26% in Ituri and 15% in Haut-Uele between August 31 and September 20, highlighting how differently the outbreak is behaving across provinces.

More Treatment Centres May Not Be Enough

The country has rapidly increased its capacity to treat patients. By September 1, affected provinces had 59 facilities with 1,346 beds, compared with just one nine-bed treatment centre when the response began in May. More than 4,000 additional health workers had also been deployed.

But beds and buildings can only help if there are enough people to staff them. According to WHO officials, an Ebola treatment centre can require around 300 healthcare professionals, including doctors, nurses, anaesthetists and hygiene staff. Some newly established centres therefore do not have enough personnel to operate at full capacity.

This creates a difficult situation of treatment infrastructure being expanded, but the workforce needed to run it is not keeping pace.

Also read: DR Congo Begins Ebola Vaccinations Targeting 20,000 Health Workers As Fatalities Cross 3,500

Ebola Pressure On Health Workers

Ebola treatment is particularly laborious as healthcare workers must provide intensive care while following strict infection-prevention measures.

Patients may require monitoring for dehydration, bleeding and other complications, while staff must work in protective equipment and follow procedures designed to prevent transmission.

The response has also been impacted by insecurity, population displacement, movement between communities and a strike by some health workers over unpaid wages. These factors can make it harder to maintain staffing.

Early treatment is key as many patients are still reaching healthcare facilities late. WHO previously reported that around 60% of weekly Ebola deaths were occurring in communities rather than treatment centres, pointing to delays in detection and access to care.

Also read: Ebola Transmission Falls In Some Areas Of Congo, But Outbreak Still Kills: WHO

Early Treatment Is Important

Ebola can cause fever, weakness, vomiting, diarrhoea and, in severe cases, bleeding and organ failure. The longer a severely ill patient remains without appropriate supportive care, the harder the disease can be to manage. Treatment centres help isolate infectious patients helps break transmission chains.

Children are another major concern in the current outbreak. Nearly one in four confirmed cases are children, but they account for almost one in three deaths. Children under five have been particularly vulnerable as more than 60% of confirmed cases in this age group resulting in death, compared to fewer than 30% among adults, according to WHO.

Developments In Vaccine & Treatment So Far

The outbreak has been identified as being caused by Bundibugyo virus, one of the viruses in the Ebola family. WHO reported a case fatality ratio of 48.3% among confirmed cases in the DRC as of September 7.

There is currently no approved vaccine or specific treatment for Bundibugyo ebolavirus, which means, health officials are completely relying on breaking transmission chain and providing prompt medical care to control the spread.

But the latest unfortunate developments point to a problem that could make containment even more challenging. The response desperately needs enough trained people, supplies and access to affected communities.

As there is currently no vaccine for Bundibugyo virus, health authorities have approved 70,000 doses of Ervebo, vaccine meant for a much familiar Zaire strain of Ebola. Health workers in DRC have begun receiving the Ervebo doses as part of an experimental trial to test if it would work on current Ebola outbreak.

With speed, sudden drops and dizzying twists at hundreds of feet in the air, roller coasters are meant to give riders an adrenaline rush and thrill. But a recent incident related to brain bleeding has shed light on the harmful impact of these extreme movements inside the brain.

A recent investigation found discovered that serious brain injuries have been allegedly linked to the X2 roller coaster at Six Flags Magic Mountain in California.

According to CNN, more than 100 people have allegedly suffered brain injuries after riding the attraction over the past two years. Three lawsuits were filed this week against Six Flags.

Two women who rode X2 just six days apart in July suffered severe brain haemorrhages and required emergency surgery. Doctors treating them attributed their injuries to rapid acceleration and deceleration experienced during the ride.

The cases raise the medical question of what happens to the brain when the body is subjected to sudden, powerful changes in speed and direction?

Can Roller Coasters Cause Brain Bleeds?

The brain is surrounded by cerebrospinal fluid, which cushions it against everyday movements and minor impacts. However, this protection has its own limits.

When a roller coaster suddenly accelerates, brakes or changes direction, the head and brain may not always necessarily move at exactly the same speed.

The brain can shift, stretch or rotate within the skull, placing strain on delicate blood vessels and nerve fibres. In extreme circumstances, these forces can tear blood vessels and cause bleeding inside the skull.

So it's not necessary that a person needs to hit their head against a hard surface to sustain a traumatic brain injury. Rapid rotational movements alone can sometimes cause significant damage to the brain.

Also read: Popular Organic Applesauce Recalled Due To Mold Toxin: What Is Patulin & How Dangerous It Is

What Is A Subdural Haematoma?

A subdural haematoma is a life threatening brain injury, in which the blood collects between the brain's outer protective covering, called the dura mater, and the brain's surface.

Sudden acceleration and deceleration can tear the veins that connect the brain to its surrounding structures.

As blood accumulates, pressure inside the skull increases. This can compress brain tissue and, in severe cases, require emergency surgery to remove the blood and relieve pressure.

Also read: Beer Is Getting A 'Health Makeover': Do Protein Or Electrolytes Really Make It Healthier?

G-Forces Are Another Factor

G-force means the acceleration experienced by the body relative to Earth's gravity. During sharp turns, steep drops and sudden brakes, roller coaster riders experience changing G-forces. However, G-force alone does not determine whether someone will sustain a brain injury.

The speed and direction of head movements, specially rapid rotation, may also contribute to brain bleeds. A small 2017 study found that roller coasters could produce brain movement and strain comparable to mild football headers. However, the researchers did not find evidence of an immediate risk of acute brain injury on the rides studied.

Warning Signs After Riding A Roller Coaster

Serious neurological injuries associated with roller coasters are considered to be rare. The Six Flags cases do not establish that an ordinary roller coaster rides will have the same risks as X2.

People with existing vascular abnormalities, previous head injuries or those taking blood-thinning medications may face additional risks.

A headache after a roller coaster ride may seem harmless, but certain symptoms require immediate medical attention.

According to the US Centers for Disease Control and Prevention, warning signs of a traumatic brain injury include worsening headaches, repeated vomiting, confusion, slurred speech, seizures, weakness and loss of consciousness. Symptoms can appear immediately or develop hours later.

A popular organic applesauce has been recalled in the US after routine testing by the US Food and Drug Administration (FDA) revealed high levels of patulin, a toxin produced by certain molds that can grow on apples.

Wakefern Food Corp. voluntarily recalled select containers of Wholesome Pantry Organic Unsweetened Apple Sauce after the patulin levels were found to exceed food safety limits. No illnesses linked to the toxin have been reported yet.

The recall involves 23-ounce plastic jars with UPC 04119005677 and a best-by date of June 16, 2027. The product was sold through ShopRite, Price Rite Marketplace, The Fresh Grocer, Gourmet Garage and Fairway Market.

What Is Patulin?

Patulin is a mycotoxin, meaning it is a toxic chemical produced by certain species of fungi or mold.

The FDA identifies molds from genera including Penicillium, Aspergillus and Byssochylamys as sources of patulin. Apples are one of the best-known sources, particularly when fruit is bruised, damaged, rotten or improperly stored.

When contaminated apples are used to make products like apple juice or applesauce, the toxin can remain it. The pasteurisation does not eliminate patulin, so simply heating an apple product is not a reliable way to get rid of the toxin.

Also read: Beer Is Getting A 'Health Makeover': Do Protein Or Electrolytes Really Make It Healthier?

How Dangerous Is Patulin?

The health concern depends on the amount and duration of exposure to patulin. According to the FDA, consuming food or beverages containing high levels of patulin may cause nausea and vomiting, while evidence also indicates that the toxin can damage cells. The agency monitors patulin because prolonged exposure to elevated levels may pose a serious health hazard.

The FDA has established an action level of 50 parts per billion (ppb) for patulin in apple juice, apple juice concentrates and apple juice products.

This does not mean that eating a food once above the regulatory limit automatically causes poisoning. Food safety limits are designed to control exposure and reduce potential health risks, particularly when contamination could occur repeatedly.

Also read: Alzheimer's Day: Why Can A Patient Remember An Event From Decades Ago But Forget What Happened This Morning?

Patulin In Applesauce

Molds formed due to patulin can grow on apples that have been bruised, damaged or allowed to rot. Contamination can also happen during storage.

The problem can be difficult to identify simply by looking at the finished food. FDA guidance notes that some contamination can originate from internal problems like core rot that may not be obvious from the outside of an apple. Removing damaged fruit before processing is therefore an important control measure.

So, anyone who has the recalled Wholesome Pantry Organic Unsweetened Apple Sauce at home should not consume it.

Consumers should check the jar for the 23-ounce size, UPC 04119005677 and best-by date June 16, 2027. The company says recalled products can be returned to the store for a refund or replacement.